Tag: Blockmir CD5-2
Researchers discover novel drug that shows potential in treating advanced liver cancer
Researchers at the Centenary Institute have identified a potential breakthrough in the treatment of hepatocellular carcinoma (HCC), the most prevalent form of liver cancer and the third leading cause of cancer-related deaths worldwide.
Featured Article
The future of sports manufacturing: Inside M2M Group’s AI-powered strategy
As the sports manufacturing industry evolves, artificial intelligence (AI) is emerging as a critical catalyst for innovation and efficiency.
